Academic Journal
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis
| العنوان: | Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis |
|---|---|
| المؤلفون: | Zerbit, Jeremie, Kroemer, Marie, Fuchs, Basile, Detroit, Marion, Decroocq, Justine, Vignon, Marguerite, Willems, Lise, Deau-Fischer, Bénédicte, Franchi, Patricia, Deschamps, Paul, Contejean, Adrien, Grignano, Eric, Fouquet, Guillemette, Birsen, Rudy, Mondesir, Johanna, Rocquet, Mathieu, Huon, Jean-François, Batista, Rui, Marty-Reboul, Jeanne, Bouscary, Didier |
| المساهمون: | Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Hôpital Cochin AP-HP, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Ligue Nationale Contre le Cancer - Paris, Ligue Nationale Contre le Cancer (LNCC), Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois, Centre Hospitalier Sud Francilien, Hôpital Necker - Enfants Malades AP-HP, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR des Sciences Pharmaceutiques et Biologiques (Nantes Univ - UFR Pharmacie), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ) |
| المصدر: | ISSN: 0961-5423. |
| بيانات النشر: | HAL CCSD Wiley |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | blood cancers, economic, leukaemia, lymphoma, myeloma, pharmacist, MESH: Humans, MESH: Pharmacists, MESH: Prospective Studies, MESH: Pharmacy Service, Hospital, MESH: Neoplasms, MESH: Cost-Benefit Analysis, MESH: Antineoplastic Agents, MESH: Hematology, MESH: Pharmaceutical Preparations, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology |
| الوصف: | International audience ; Objective: The clinical benefit of pharmaceutical cares in improving the quality-of-care outcomes is well demonstrated. Clinical pharmacy services are not systematically deployed in cancer units in the absence of economic data. The aim of this prospective, observational 1-year study was to evaluate the clinical, economic and organisational impacts of pharmaceutical care into a multidisciplinary day hospital for patients treated with oral cancer drugs.Methods: All pharmacists' interventions (PI) were documented and their impact and the probability of adverse drug events were assessed using the clinical, economic and organisational tool.Results: Among 360 admissions, an average of 1.81 PI per admission was accepted. Among 452 PI leading to a clinical benefit on the patient, 16.9% had a major impact, and 1.9% had an impact on survival. The large majority of PIs (87%) increased the quality-of-care organisation. The budget impact model showed a total cost savings and cost avoidance of €539,047 per year and a cost-benefit ratio of 7.07:1. The direct cost-benefit was €201,741, and the cost avoidance was €337,306.Conclusion: Multidisciplinary care and pharmaceutical care are key elements to improve cancer patients' outcomes and avoid evitable healthcare costs. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/36273820; PUBMED: 36273820 |
| DOI: | 10.1111/ecc.13753 |
| الاتاحة: | https://nantes-universite.hal.science/hal-04795568 https://doi.org/10.1111/ecc.13753 |
| Rights: | http://hal.archives-ouvertes.fr/licences/copyright/ |
| رقم الانضمام: | edsbas.8DBAA9F2 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1111/ecc.13753 |
|---|